Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewMed Energy LPDKDRF 70 5-Year Yield-on-Cost % is 25.17 as of Jul. 27, 2026, which is 19% below its 10-year median of 30.95. GuruFocus rates DKDRF with a GF Score™ of 70/100 and a GF Value™ of $2.89 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 500 Oil & Gas companies, NewMed Energy LP ranks better than 94.2% on this metric.
NewMed Energy LP's yield on cost for the quarter that ended in Mar. 2026 was 25.17.
The historical rank and industry rank for NewMed Energy LP's 5-Year Yield-on-Cost % or its related term are showing as below:
DKDRF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.52 Med: 30.95 Max: 125.73
Current: 25.17
During the past 13 years, NewMed Energy LP's highest Yield on Cost was 125.73. The lowest was 4.52. And the median was 30.95.
DKDRF's 5-Year Yield-on-Cost % is ranked better than 94.2% of 500
companies
in the Oil & Gas industry
Industry Median: 4.835
vs DKDRF: 25.17
NewMed Energy LP (OTCPK:DKDRF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
NewMed Energy LP 5-Year Yield-on-Cost % Related Terms
DKDRF vs COP, EOG, FANG: 5-Year Yield-on-Cost % Comparison
For the Oil & Gas E&P subindustry, NewMed Energy LP's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewMed Energy LP 5-Year Yield-on-Cost % vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, NewMed Energy LP's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where NewMed Energy LP's 5-Year Yield-on-Cost % falls into.
NewMed Energy LP 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
NewMed Energy LP (DKDRF) has a 5-Year Yield-on-Cost % of 25.17 as of Jul. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on NewMed Energy LP and its competitors. This is 19% below median its historical median of 30.95. Over the past decade, NewMed Energy LP's 5-Year Yield-on-Cost % has ranged from 4.52 to 125.73. According to the industry distribution chart, NewMed Energy LP ranks #29 out of 500 companies in the Oil & Gas industry, placing it in the top 5.8%.
Is NewMed Energy LP's 5-Year Yield-on-Cost % too high?
NewMed Energy LP's current 5-Year Yield-on-Cost % of 25.17 is 19% below median its 10-year median of 30.95. Over the past 10 years, this metric has ranged from a low of 4.52 to a high of 125.73. The Oil & Gas industry median 5-Year Yield-on-Cost % is 4.84. NewMed Energy LP's value of 25.17 is 420.6% above this industry median. Based on the distribution chart, NewMed Energy LP ranks #29 out of 500 companies in the Oil & Gas industry, which is in the top quartile — a strong position relative to peers. Overall, NewMed Energy LP has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's 5-Year Yield-on-Cost % compare to COP and EOG?
According to the Oil & Gas industry distribution chart, NewMed Energy LP ranks #29 out of 500 companies for 5-Year Yield-on-Cost %. This places NewMed Energy LP in the top 6% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 4.84. NewMed Energy LP's value of 25.17 is 420.6% above this benchmark. Historically, NewMed Energy LP's own 5-Year Yield-on-Cost % has ranged from 4.52 to 125.73 over the past decade. While the company's 10-year median is 30.95 vs. the industry median of 4.84, NewMed Energy LP has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Oil & Gas company?
The median 5-Year Yield-on-Cost % among Oil & Gas companies is 4.84, based on 500 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMed Energy LP's current 5-Year Yield-on-Cost % of 25.17 is 420.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on NewMed Energy LP and its competitors. For the Oil & Gas industry, the median 5-Year Yield-on-Cost % is 4.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMed Energy LP's current 5-Year Yield-on-Cost % is 25.17, which is 19% below median its own 10-year median of 30.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.89, compared to a current price of $5.10 — trading 76.5% above its estimated fair value. The current 5-Year Yield-on-Cost % is 25.17, which is 19% below median its 10-year median of 30.95 and 420.6% above the Oil & Gas industry median of 4.84. NewMed Energy LP's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current 5-Year Yield-on-Cost % is 25.17 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NewMed Energy LP (DKDRF) Overvalued in 2026?
Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued.
The current stock price of $5.10 is trading 76.5% above its estimated GF Value™ of $2.89.
GuruFocus considers NewMed Energy LP to be Significantly Overvalued.
Key valuation signals for DKDRF:
5-Year Yield-on-Cost %: 25.17 (19% below median its 10-year median of 30.95)
GF Value™: $2.89 vs. price of $5.10 (76.5% above fair value)
Industry Position: 420.6% above the Oil & Gas median (#29 of 500)
No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
70GF Score
Get the complete analysis for DKDRF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DKDRF has been successfully added to your 
